4Dmedical Financials

4DX Stock   0.46  0.01  2.22%   
We suggest to use 4Dmedical analysis to find out if markets are now mispricing the company. We have analyzed and interpolated twenty-six available fundamental indicators for 4Dmedical, which can be compared to its peers. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of 4Dmedical to be traded at 0.552 in 90 days. Key indicators impacting 4Dmedical's financial strength include:
Operating Margin
(7.55)
EPS Estimate Current Year
(0.08)
Return On Equity
(0.51)
  
Understanding current and past 4Dmedical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of 4Dmedical's financial statements are interrelated, with each one affecting the others. For example, an increase in 4Dmedical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in 4Dmedical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of 4Dmedical. Check 4Dmedical's Beneish M Score to see the likelihood of 4Dmedical's management manipulating its earnings.

4Dmedical Stock Summary

4Dmedical competes with Aneka Tambang, Woolworths, Commonwealth Bank, BHP Group, and Rio Tinto. 4Dmedical is entity of Australia. It is traded as Stock on AU exchange.
Foreign Associate
  Germany
Specialization
Health Care, Health Care Equipment & Services
InstrumentAustralia Stock View All
ExchangeAustralian Securities Exchange
ISINAU0000095416
Business AddressMelbourne Connect, Carlton,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Website4dmedical.com
Phone61 3 9545 5940
You should never invest in 4Dmedical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of 4Dmedical Stock, because this is throwing your money away. Analyzing the key information contained in 4Dmedical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

4Dmedical Key Financial Ratios

4Dmedical's financial ratios allow both analysts and investors to convert raw data from 4Dmedical's financial statements into concise, actionable information that can be used to evaluate the performance of 4Dmedical over time and compare it to other companies across industries.

4Dmedical Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets15.8M92.6M74.3M92.9M120.0M126.0M
Other Current Liab9.0M969.8K6.6M11.6M18.5M19.4M
Net Debt8.1M(79.2M)(44.9M)(64.4M)(25.5M)(26.8M)
Retained Earnings(38.6M)(60.0M)(84.6M)(116.1M)(152.0M)(144.4M)
Accounts Payable1.7M448.2K1.8M2.9M2.1M1.1M
Cash8.4M80.9M51.1M69.6M30.6M27.1M
Inventory16.0K153.4K1.5K665.0K992.2K1.0M
Other Current Assets489.0K4.4M1.4M7.5M6.2M6.5M
Total Liab27.6M9.3M14.8M21.5M49.1M51.5M
Total Current Assets10.3M85.8M58.9M78.5M39.1M31.3M
Intangible Assets512.9K3.9M5.1M5.1M29.5M30.9M
Common Stock18.9M141.6M141.7M184.4M218.4M229.4M
Other Liab55.3K146.6K104.6K185.8K213.7K224.3K
Net Tangible Assets(12.3M)82.7M58.5M70.4M81.0M85.1M
Other Assets2.9M3.3M4.1M4.1M4.7M2.5M
Net Receivables1.8M426.6K6.4M815.0K1.3M1.7M
Long Term Debt Total621.2K965.4K5.1M4.2M4.8M5.1M
Short Term Debt16.2M723.5K1.1M933.1K944.6K897.4K

4Dmedical Key Income Statement Accounts

201920202021202220232024 (projected)
Total Revenue1.2M217.0K1.1M282.2K3.8M3.9M
Gross Profit(8.1M)125.1K280.6K248.0K3.5M3.7M
Operating Income(16.0M)(18.8M)(36.8M)(31.1M)(28.0M)(26.6M)
Ebit(16.4M)(18.8M)(37.8M)(36.3M)(35.9M)(34.1M)
Ebitda(15.8M)(18.0M)(36.3M)(33.7M)(31.9M)(30.3M)
Cost Of Revenue9.4M91.9K773.7K34.1K236.7K224.9K
Income Before Tax(22.8M)(21.4M)(24.5M)(31.1M)(40.4M)(38.4M)
Net Income(22.0M)(21.4M)(24.6M)(31.5M)(36.0M)(34.2M)
Tax Provision1.8K15.3K43.2K323.2K48.4K60.0K
Interest Expense8.0M2.6M179.6K6.5K264.0K250.8K
Income Tax Expense(818.0K)15.3K43.2K323.2K(4.4M)(4.2M)
Interest Income8.0M2.7M92.6K313.6K1.2M1.4M
Research Development3.5M2.4M4.4M4.0M694.5K659.8K

4Dmedical Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory612.7K(137.3K)(273.1K)(663.5K)327.2K343.6K
Change In Cash5.3M72.5M(29.8M)18.5M(39.0M)(37.0M)
Free Cash Flow(8.8M)(15.2M)(28.3M)(23.4M)(31.2M)(29.6M)
Depreciation584.7K741.5K1.5M2.6M4.1M4.3M
Other Non Cash Items9.8M1.5M582.1K1.4M344.1K326.9K
Capital Expenditures1.2M725.0K3.1M731.3K302.9K287.7K
Net Income(22.0M)(21.4M)(24.6M)(31.5M)(36.0M)(34.2M)
End Period Cash Flow8.4M80.9M51.1M69.6M30.6M27.1M
Net Borrowings14.1M(533.7K)(995.5K)170.6K153.5K145.8K
Change To Netincome10.8M1.5M582.1K1.4M1.7M2.4M

4Dmedical Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining 4Dmedical's current stock value. Our valuation model uses many indicators to compare 4Dmedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 4Dmedical competition to find correlations between indicators driving 4Dmedical's intrinsic value. More Info.
4Dmedical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the 4Dmedical's earnings, one of the primary drivers of an investment's value.

4Dmedical Systematic Risk

4Dmedical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. 4Dmedical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on 4Dmedical correlated with the market. If Beta is less than 0 4Dmedical generally moves in the opposite direction as compared to the market. If 4Dmedical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one 4Dmedical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of 4Dmedical is generally in the same direction as the market. If Beta > 1 4Dmedical moves generally in the same direction as, but more than the movement of the benchmark.

4Dmedical Total Assets Over Time

4Dmedical Thematic Clasifications

4Dmedical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
DrugsView
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas

4Dmedical December 28, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of 4Dmedical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of 4Dmedical. We use our internally-developed statistical techniques to arrive at the intrinsic value of 4Dmedical based on widely used predictive technical indicators. In general, we focus on analyzing 4Dmedical Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build 4Dmedical's daily price indicators and compare them against related drivers.

Additional Tools for 4Dmedical Stock Analysis

When running 4Dmedical's price analysis, check to measure 4Dmedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4Dmedical is operating at the current time. Most of 4Dmedical's value examination focuses on studying past and present price action to predict the probability of 4Dmedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4Dmedical's price. Additionally, you may evaluate how the addition of 4Dmedical to your portfolios can decrease your overall portfolio volatility.